Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024)
Harvard Bioscience (HBIO) reported Change in Acquisitions & Divestments of $1.4 million for Q3 2024, little changed quarter-over-quarter from $1.4 million in Q2 2024.
Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024) Analysis & Trends
Harvard Bioscience (HBIO) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $1.4 million in Q3 2024.
- Change in Acquisitions & Divestments for Q3 2024 came in at $1.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $1.4 million (down 26.12% YoY), and the FY2024 annual result was $1.9 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments held at $1.4 million in Q3 2024 per HBIO's latest filing, from $1.4 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $1.4 million in Q2 2024 and troughed at $495000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 495,000.00 |
| Mar 31, 2024 | 495,000.00 |